The Trendlines Group | January 2022


 



The Trendlines Group Trendletter | January 2022

“FruitSpec raises… AgroScout acquires… Trendlines 2021 achievements…”

NEWS

 

FruitSpec, raises $5M funding round to scale globally…
Read more.
 

Waston Medical and Trendlines Labs collaborate for Chinese/Israeli medical device…. Read more.
 

Seger develops next gen laparoscopic bowel closure device… Read more.
 

SOLVEAT joins Trendlines portfolio… Read more.
 

MetoMotion secured its first commercial sales contracts for 2022 in The Netherlands and the Far East…. Read more.

 

AgroScout acquires the assets of TerrAvion to broaden its imagery capabilities… Read more.
 

ZygoFix selected to receive €5.4M in funding from the prestigious EU EIC program… Read more.
 

Calon Cardio-Technology and Leviticus-Cardio announced the joint development…Read more.
 

Trendlines invests in AgriG8
Read more.
 

Dr. Ami Appelbaum and Dr. Einat Magal from the Israel Innovation Authority visited Trendlines… Read more.

Pull up a chair and get your popcorn! Steve Rhodes and Todd Dollinger, present selected achievements of The Trendlines Group in 2021.

 

IN THE MEDIA

  • Trendlines China Director Eddy Wang, was interviewed about Trendlines’ role in the China-Israel Innovation Park… Read more.
  • Hargol, Phytolon and Equinom featured in ‘Israel’s 50+ FoodTech Unicorns, Soonicorns and Futurecorns’ Read more.
  • Phytolon CEO Halim Jubran was included in an article ’12 on 12: The influential figures in Israeli food technology’ (Hebrew) Read more.

NOW FUNDING



Elastimed is now funding on ExitValley. ElastiMed has developed a wearable device designed to improve leg circulation, to treat venous and lymphatic diseases. The patented invention is expected to treat swelling, prevent DVT and reduce sports recovery time. Learn more.

 

COMING UP

  • Trendlines Investments Israel CEO Barak Singer will be participating as a judge at Unicorn Battle in HealthTech, January 27 2022, Register here.
  • Trendlines VP of Business Development Ofir Hazut will be speaking at the Access China Biotech Forum at JPM Week 2022… Register here.
  • The Trendlines’ 3i Accelerator Program is open for applications… Apply here.



OPEN POSITIONS